4D Pharma shares leap on successful trial for cancer drug
Live biotherapeutics company 4D Pharma (DDDD:AIM) released positive interim results from a cancer trial which showed its therapeutic treatment in combination Merck's KEYTRUDA met its goals early.The shares surged by 32% to 59.2p as...
23 March 2022
